Since these melanoma cells do not express CSPG4, a suspected mechanism of action of this DNA vaccination was through triggering an immune response targeting the CSPG4-expressing pericytes in tumour blood vessels [101]. This evidence concerns the gene CSPG4 and neoplasm.